Skip to main content
. 2017 Aug 17;11(9):353–373. doi: 10.1177/1753465817725486

Figure 3.

Figure 3.

New first-line treatment algorithm for advanced NSCLC.

ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; FISH, fluorescent in situ hybridization; IHC, immunohistochemistry; NSCLC, non-small cell lung cancer; PD-L1, programmed death-ligand 1; TTF, thyroid transcription factor.